TMC LIFE SCIENCES |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7 MYR | +2.94% |
|
+0.72% | -2.10% |
| Feb. 05 | TMC Life Sciences' Profit More Than Doubles in Fiscal Q2 | MT |
| Feb. 02 | TMC Life Sciences Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
| Sales 2022 | 244M 51M | Sales 2023 | 312M 65.18M | Capitalization | 1.05B 219M |
|---|---|---|---|---|---|
| Net income 2022 | 41M 8.58M | Net income 2023 | 39M 8.16M | EV / Sales 2022 | 3.92 x |
| Net Debt 2022 | 67.3M 14.08M | Net Debt 2023 | 50.36M 10.54M | EV / Sales 2023 | 3.52 x |
| P/E ratio 2022 |
21.5
x | P/E ratio 2023 |
26.7
x | Employees | - |
| Yield 2022 |
0.54% | Yield 2023 |
0.7% | Free-Float | 16.85% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.94% | ||
| 1 week | +0.72% | ||
| 1 month | -2.78% | ||
| 3 months | -2.78% | ||
| 6 months | +18.64% | ||
| Current year | -2.10% |
1 week
0.67
0.70
1 month
0.670.73
Current year
0.670.81
1 year
0.560.81
3 years
0.480.81
5 years
0.370.82
10 years
0.370.99
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 40 | 17-06-18 | |
Yu Chee Wong
DFI | Director of Finance/CFO | 51 | 15-08-02 |
Mok Shi-Lynn
IRO | Public Communications Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 23-05-18 | |
Ho Chee Cheah
BRD | Director/Board Member | 53 | 22-06-30 |
Kheong Ng Kan
BRD | Director/Board Member | 68 | 15-06-01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 0.7 | +2.94% | 308,100 |
| 24-04-23 | 0.68 | +0.74% | 394,500 |
| 24-04-22 | 0.675 | 0.00% | 546,600 |
| 24-04-19 | 0.675 | -2.17% | 1,296,400 |
| 24-04-18 | 0.69 | -0.72% | 278,000 |
End-of-day quote BURSA MALAYSIA, April 23, 2024
More quotes
TMC Life Sciences Berhad is a Malaysia-based investment holding company. The Companyâs segments include Thomson Hospitals Sdn. Bhd., IVF Technologies Sdn. Bhd., TMC Lifestyle Sdn. Bhd., TMC Properties Sdn. Bhd., Thomson TCM Sdn. Bhd., BB Waterfront Sdn. Bhd., TMC Care Sdn. Bhd. and others. Thomson Hospitals Sdn. Bhd provides multi-disciplinary tertiary care services. IVF Technologies Sdn. Bhd. provides fertility services and operation of womenâs clinic. TMC Lifestyle Sdn. Bhd. is engaged in the development, marketing and management of healthcare programs, and provision of fertility consultancy, laboratory and embryology services and research and development. TMC Properties Sdn. Bhd. is involved in property investment. Thomson TCM Sdn. Bhd. is involved in the provision of traditional and complementary services. BB Waterfront Sdn. Bhd. is involved in the provision of healthcare services. TMC Care Sdn. Bhd. offers pharmacy services and products, and management support services.
Calendar
2024-05-20
- Q3 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -2.10% | 248M | |
| -24.40% | 15.55B | |
| +1.80% | 12.05B | |
| +2.82% | 11.5B | |
| +10.15% | 10.69B | |
| +24.10% | 8.26B | |
| -0.40% | 7.79B | |
| +22.90% | 7.31B | |
| +5.73% | 6.75B | |
| +50.39% | 4.51B |
- Stock Market
- Equities
- TMCLIFE Stock
